ONCY

#3426
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.04
1.04
Rango anual
0.33
1.51
Cambio diario
+10.64%
Variación mensual
+14.29%
Variación en los últimos 6 meses
+4.00%
Cambio anual
+173.68%
Cierres anteriores
0.9 4
Open
1.0 4
Mínimo
1.0 4
High
1.0 4
Volumen
30
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q4, 25Q1, 26 TTM

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Noticias